Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 120(7): e2208509120, 2023 02 14.
Artigo em Inglês | MEDLINE | ID: mdl-36745791

RESUMO

Antigenic peptides derived from introns are presented on major histocompatibility (MHC) class I molecules, but how these peptides are produced is poorly understood. Here, we show that an MHC class I epitope (SL8) sequence inserted in the second intron of the ß-globin gene in a C57BL/6 mouse (HBB) generates immune tolerance. Introduction of SL8-specific CD8+ T cells derived from OT-1 transgenic mice resulted in a threefold increase in OT-1 T cell proliferation in HBB animals, as compared to wild-type animals. The growth of MCA sarcoma cells expressing the intron-derived SL8 epitope was suppressed in wild-type animals compared to HBB mice. The ß-globin pre-mRNA was detected in the light polysomal fraction, and introducing stop codons identified a non-AUG initiation site between +228 and +255 nts upstream of the SL8. Isolation of ribosome footprints confirmed translation initiation within this 27 nt sequence. Furthermore, treatment with splicing inhibitor shifts the translation of the pre-mRNA to monosomal fractions and results in an increase of intron-derived peptide substrate as shown by polysome profiling and cell imaging. These results show that non-AUG-initiated translation of pre-mRNAs generates peptides for MHC class I immune tolerance and helps explain why alternative tissue-specific splicing is tolerated by the immune system.


Assuntos
Antígenos de Histocompatibilidade Classe I , Precursores de RNA , Animais , Camundongos , Antígenos de Histocompatibilidade Classe I/genética , Precursores de RNA/genética , Linfócitos T CD8-Positivos , Biossíntese de Proteínas , Apresentação de Antígeno , Camundongos Endogâmicos C57BL , Peptídeos/metabolismo , Tolerância Imunológica/genética , Epitopos , Antígenos de Histocompatibilidade Classe II/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA